Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Fatigue and tiredness are listed as common adverse reactions in the Summary of Product Characteristics (SmPC) for both semaglutide (Wegovy) and liraglutide (Saxenda) as approved by the Medicines and Healthcare products Regulatory Agency (MHRA)
Here is why precision matters at every step
So, you will see the best result quickly
Cardiac / vascular endpoints: IP parenteral for acute models
US$ 22.57
US$ 21.90
US$ 25.39
US$ 24.59
US$ 28.27
